$300 | Single User
$600 | Site License
$900 | Global License

Xvivo Perfusion AB (XVIVO) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

Published by Global Data: 09 Mar 2018 | 196068 | In Stock

Introduction

Summary

Xvivo Perfusion AB (Xvivo), a subsidiary of Bure Equity AB is a medical technology company that offers organ transplantation solutions. The company develops organ preservation products which include perfadex and silicone tubing sets and normothermic perfusion products. Its normothermic perfusion products include STEEN solutions, XVIVO organ chambers, XVIVO lung cannula sets and XPS-XVIVO perfusion systems. Xvivo develops its products based on ex vivo lung perfusion technology. The company markets its products in Italy, Sweden, Turkey, Israel, India, Japan, the US, Brazil, and others. Xvivo is headquartered in Gothenburg, Sweden.

Xvivo Perfusion AB Key Recent Developments

Feb 09,2018: XVIVO Perfusion Report on Operations 2017

Nov 07,2017: Reimbursement codes obtained for doctor´s time during EVLP procedure

Oct 27,2017: XVIVO Perfusion: Interim Report January – September 2017

Sep 12,2017: First clinical heart transplant performed using Stig Steen’s new method

Jul 17,2017: XVIVO Perfusion's CFO appointed Deputy CEO

This comprehensive SWOT profile of Xvivo Perfusion AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Xvivo Perfusion AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Table of Contents
for Xvivo Perfusion AB (XVIVO) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

  • Table of Contents

    Section 1 - About the Company

    Xvivo Perfusion AB - Key Information

    Xvivo Perfusion AB - Overview

    Xvivo Perfusion AB - Key Employees

    Xvivo Perfusion AB - Key Employee Biographies

    Xvivo Perfusion AB - Key Operational Heads

    Xvivo Perfusion AB - Major Products and Services

    Xvivo Perfusion AB - History

    Xvivo Perfusion AB - Company Statement

    Xvivo Perfusion AB - Locations And Subsidiaries

    Xvivo Perfusion AB - Key Manufacturing facilities

    Head Office

    Other Locations & Subsidiaries

    Section 2 - Company Analysis

    Xvivo Perfusion AB - Business Description

    Xvivo Perfusion AB - Corporate Strategy

    Xvivo Perfusion AB - SWOT Analysis

    SWOT Analysis - Overview

    Xvivo Perfusion AB - Strengths

    Xvivo Perfusion AB - Weaknesses

    Xvivo Perfusion AB - Opportunities

    Xvivo Perfusion AB - Threats

    Xvivo Perfusion AB - Key Competitors

    Section 3 - Company Financial Performance Charts

    Xvivo Perfusion AB - Financial Ratios

    Financial Ratios - Capital Market Ratios

    Financial Ratios - Annual Ratios

    Financial Ratios - Interim Ratios

    Financial Ratios - Ratio Charts

    Section 4 - Appendix

    Appendix

    Methodology

    Ratio Definitions

    About GlobalData

    Contact Us

    Disclaimer

    Note*: Some sections may be missing if data is unavailable for the company

List Of Tables
in Xvivo Perfusion AB (XVIVO) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

List of Tables


Xvivo Perfusion AB, Key Information

Xvivo Perfusion AB, Key Ratios

Xvivo Perfusion AB, Share Data

Xvivo Perfusion AB, Major Products and Services

Xvivo Perfusion AB, History

Xvivo Perfusion AB, Key Employees

Xvivo Perfusion AB, Key Employee Biographies

Xvivo Perfusion AB, Key Operational Heads

Xvivo Perfusion AB, Other Locations

Xvivo Perfusion AB, Subsidiaries

Xvivo Perfusion AB, Key Manufacturing facilities

Xvivo Perfusion AB, Key Competitors

Xvivo Perfusion AB, SWOT Analysis

Xvivo Perfusion AB, Ratios based on current share price

Xvivo Perfusion AB, Annual Ratios

Xvivo Perfusion AB, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures, Charts and Diagrams
in Xvivo Perfusion AB (XVIVO) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

List of Figures


Xvivo Perfusion AB, Performance Chart

Xvivo Perfusion AB, Ratio Charts

Additional Details

Publisher

Global Data

Publisher Information

Reference

196068 | GDME290181FSA

Number of Pages

25

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Xvivo Perfusion AB (XVIVO) - Financial and Strategic SWOT Analysis Review
SummaryXvivo Perfusion AB (Xvivo), a subsidiary of Bure Equity AB is a medical technology company th...
13 Nov 2017 by Global Data USD $300 More Info
Xvivo Perfusion AB (XVIVO) - Financial and Strategic SWOT Analysis Review
SummaryXvivo Perfusion AB (Xvivo), a subsidiary of Bure Equity AB is a medical technology company th...
07 Aug 2017 by Global Data USD $300 More Info
Xvivo Perfusion AB (XVIVO) - Financial and Strategic SWOT Analysis Review
SummaryXvivo Perfusion AB (Xvivo) is a medical technology company that designs and develops products...
15 May 2017 by Global Data USD $300 More Info
Xvivo Perfusion AB (XVIVO) - Financial and Strategic SWOT Analysis Review
SummaryXvivo Perfusion AB (Xvivo) is a medical technology company that designs and develops products...
13 Jan 2017 by Global Data USD $300 More Info
Xvivo Perfusion AB (XVIVO) - Financial and Strategic SWOT Analysis Review
SummaryXvivo Perfusion AB (Xvivo) is a medical technology company that designs and develops products...
11 Jul 2016 by Global Data USD $300 More Info

This report is published by Global Data

Download Free Report Summary PDF

Xvivo Perfusion AB (XVIVO) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data